Pharvaris (NASDAQ:PHVS) Given New $49.00 Price Target at JMP Securities

Pharvaris (NASDAQ:PHVS – Get Free Report) had its price objective increased by equities research analysts at JMP Securities from $40.00 to $49.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a “market outperform” rating on the stock. JMP Securities’ price target indicates a potential upside of 68.97% from […]

Related Keywords

United States ,America , ,Tower Research Capital ,Morgan Stanley ,Schonfeld Strategic Advisors ,Qube Research Technologies Ltd ,America Corp ,Get Free Report ,Research Capital ,Technologies Ltd ,Pharvaris Daily ,Pharvaris ,Nasdaq Phvs ,Phvs ,Medical ,Boost Price Target ,Jmp Securities ,